Wednesday, June 25, 2014
Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5 million via a senior secured term loan facility.
http://bit.ly/1qw9TC4
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment